DR4
Subscribe to
our newsletters!
Showing the single result
- This Target Pipeline List provides an overview of agonist antibodies and fusion proteins targeting death receptor 4 and/or 5 in development for treatment of cancer.€ 100.00
Menu
Biopharma R&D Information
&
Custom Report Preparation
La Merie Publishing is an independent business information provider for the biotechnology and pharmaceutical industry. We publish proprietary reports and prepare custom reports.